Why Moderna Stock Fell 32% in December

Shares of biotech Moderna (NASDAQ: MRNA), maker of a COVID-19 vaccine, dropped 31.6% in December, according to data from S&P Global Market Intelligence. 

For context, the S&P 500 returned 3.8% last month.

Image source: Getty Images.

Continue reading

Source Fool.com